Identification of an Immune-Related Prognostic Predictor in Hepatocellular Carcinoma

Frontiers in Molecular Biosciences
Lei WuGuihai Zhang

Abstract

Liver hepatocellular carcinoma (LIHC) is the most prevalent primary cancer of the liver, and immune-related genes (IRGs) regulate its development. So far, there is still no precise biomarker that predicts response to immunotherapy in LIHC. Therefore, this research seeks to identify immunogenic prognostic biomarkers and explore potential predictors for the efficacy of anti-PD-1/PD-L1 therapies in LIHC. The clinical data and gene expression profiles of patients diagnosed with LIHC were downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Moreover, IRGs were obtained from the ImmPort database. We discovered 35 IRGs that were differentially expressed between LIHC tissues and corresponding normal tissues. Through univariate Cox regression analysis, eight prognostic differentially expressed IRGs (PDEIRGs) were identified. Further, three optimal PDEIRGs (BIRC5, LPA, and ROBO1) were identified and used to construct a prognostic risk signature of LIHC patients via multivariate Cox regression analysis. The signature was validated by ROC curves. Subsequently, based on gene set enrichment analysis (GSEA) analysis, two out of the three optimal PDEIRGs (BIRC5 and LPA) were significantly enriched in the ...Continue Reading

References

Sep 14, 2004·Oncogene·Zhanxiang WangLouis M Pelus
Aug 27, 2005·Expert Opinion on Biological Therapy·Gavin M BendleHans J Stauss
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Feb 9, 2006·Chemical Reviews·Ravi R IyerPaul L Modrich
Dec 25, 2007·Cell Research·Guo-Min Li
Mar 23, 2010·Cell·Sergei I GrivennikovMichael Karin
Oct 28, 2010·Cancer Prevention Research·Henry T LynchC Richard Boland
Jul 15, 2011·Journal of Internal Medicine·F PonténP-H D Edqvist
Aug 24, 2011·Genome Biology·Tao LiuX Shirley Liu
Nov 9, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stéphane ChampiatCharles Ferté
Feb 12, 2017·Cell·Padmanee SharmaAntoni Ribas
Mar 8, 2017·Journal of Immunology Research·Elias J Sayour, Duane A Mitchell
Mar 30, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shumei KatoRazelle Kurzrock
Mar 11, 2018·The Oncologist·Dmitry Ratner, Jochen K Lennerz
Mar 31, 2018·Scientific Reports·Friedrich FoersterErnesto Bockamp
Aug 25, 2018·Molecular Cancer·Ming YiKongming Wu
Oct 21, 2018·Journal for Immunotherapy of Cancer·Apostolia M TsimberidouMichael A Postow
Oct 26, 2018·Scientific Reports·Myoung-Eun HanSae-Ock Oh
Feb 16, 2019·Cancer·Sanjay Popat
Mar 25, 2019·The Kaohsiung Journal of Medical Sciences·Zi-Ming HuangFeng Xu
Jul 11, 2019·Cancer·Imane El DikaGhassan K Abou-Alfa
Aug 4, 2019·Cancer Immunology, Immunotherapy : CII·Michael FriedrichBarbara Seliger
Aug 24, 2019·Nature Reviews. Gastroenterology & Hepatology·Ju Dong YangLewis R Roberts
Nov 5, 2019·Biochimica Et Biophysica Acta. Reviews on Cancer·David AnwanwanRajesh Singh
Dec 1, 2019·Journal for Immunotherapy of Cancer·Jiaqiang MaXiaoming Zhang
Mar 10, 2020·World Journal of Gastroenterology : WJG·Han-Zhang ZhuChang-Ku Jia
May 16, 2020·Frontiers in Oncology·Hongjing ZangSongqing Fan

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Datasets Mentioned

BETA
GSE101685
GSE62232
GSE84402

Software Mentioned

R package “
pheatmap R
GSEA
Tumor IMmune Estimation Resource ( TIMER )
GEPIA
R
Cytoscape
MCODE
ImmPort
limma

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.